Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955432 · ClinicalTrials.gov registry record · NA
Long-term Cardiac Monitoring in Epilepsy
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03955432 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 7 participants.
The verdict
NCT03955432, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac complications than the general population. With this study, we aim to understand more about these potential complications in patients with epilepsy and assess if treatments for cardiac problems should be evaluated more carefully in patients with epilepsy.
Interventions
- DEVICE Reveal LINQ ICM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-03-19 |
| Est. Completion | 2023-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03955432
The ClinicalTrials.gov registry entry for NCT03955432 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reveal LINQ ICM System is the first listed.
NCT03955432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03955432 about?
NCT03955432 is a clinical study titled "Long-term Cardiac Monitoring in Epilepsy". The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac com...
What is the current status of trial NCT03955432?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-03-19. Estimated completion is 2023-01-03.
What interventions are being tested in trial NCT03955432?
The interventions under investigation include: Reveal LINQ ICM System (DEVICE).
Who is sponsoring clinical trial NCT03955432?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.